Categories: Conference Coverage 2023

Conference Coverage: 2023 Precision Oncology Summit

We are excited to bring the conference coverage/highlights from the highly anticipated “2023 Precision Oncology Summit” that is taking place this weekend in the vibrant city of San Francisco. This important event features leading experts, researchers, and innovators from the field of oncology who discuss the latest advancements in precision medicine.

Meet the authors

Hannah Abrams, MD (she/her) is a fellow in Hematology/Oncology at Fred Hutchinson Cancer Center and the University of Washington. She is originally from Houston, Texas, and completed her MD at Baylor College of Medicine before completing Internal Medicine residency at Massachusetts General Hospital.

Ivy Riano, MD (she/her) is the Research Chief Fellow in the Hematology and Oncology Fellowship program at Dartmouth Cancer Center. Dr. Riano’s research interests include the development of novel immunotherapeutic combinations for patients with lung cancer, and the application of approaches to 

overcome resistance to immunotherapy. 

Abdul Moiz Khan, MD (he/his) is the Chief Fellow of the Hematology and Oncology fellowship program at Karmanos Cancer Institute / Wayne State University. His areas of interest include malignant and classical hematology, with a strong focus on myeloid malignancies and medical education.

Inas Abuali, MD, FACP (she/her) is a physician at the Massachusetts General Hospital Cancer Center and Instructor of Medicine at Harvard Medical School. She specializes in the care of hospitalized patients. She is a member of the BTF Education Academy.

Highlights from the 2023 Precision Oncology Summit

Tara Shah

Share
Published by
Tara Shah
Tags: 2023 Precision Oncology Summit
1 year ago

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

7 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

7 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

7 months ago